Trial intelligence / Profile preview

Phase I Study of RG7304 in Advanced Solid Tumors

jRCT2080221452Phase 1

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of avutometinib in Nonhematologic neoplasms, sponsored by Chugai Pharmaceutical Co., Ltd.

02

Drugs

avutometinib
03

Conditions

Nonhematologic neoplasms

Beyond the preview

Go deeper on jRCT2080221452.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221452.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call